|
Variables
| |
Included patients N = 129
|
|---|
|
Median (IQR)/N (%)
|
|---|
|
Age
|
Years
|
72 (62–78)
|
|
Sex
|
Females
|
48 (37.2)
|
|
BMI
| |
25.3 (23.4–27.8)
|
|
CCI
|
5 (4–7)
|
|
ASA score
|
1
|
4 (3.1)
|
|
2
|
66 (51.2)
|
|
3
|
59 (45.7)
|
|
Type of surgery
|
Anterior resection
|
94 (72.9)
|
|
Miles procedure
|
21 (16.3)
|
|
Hartmann procedure
|
14 (10.8)
|
|
Laparoscopy
| |
63 (48.8)
|
|
Overall morbidity
| |
43 (33.3)
|
|
Clavien-Dindo classification
|
< 3
|
27 (20.9)
|
|
≥ 3
|
15 (11.6)
|
|
Redo surgery
| |
8 (6.2)
|
|
Anastomotic leakagea
| |
8/94 (8.5)
|
|
Tumor location
|
High
|
64 (49.6)
|
|
Middle
|
41 (31.8)
|
|
Low
|
24 (18.6)
|
|
TNM stage
|
I
|
30 (23.3)
|
|
II
|
33 (25.6)
|
|
III
|
41 (31.8)
|
|
IV
|
13 (10.1)
|
|
Positive resection margin
| |
11 (8.5)
|
|
Adjuvant chemotherapy
| |
61 (47.3)
|
- BMI body mass index, CCI Charlson comorbidity index, ASA American Society of Anesthesiologists
- aCalculated on the number of patients who underwent restorative surgery
